Advertisement

Metabolic Brain Disease

, Volume 34, Issue 5, pp 1341–1353 | Cite as

Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence

  • Sriranjini Venkata RaoEmail author
  • P. Hemalatha
  • S. Yetish
  • M. Muralidhara
  • Padmanabhan S. Rajini
Original Article

Abstract

Previously we have demonstrated the potential neuroprotective propensity of saffron and Crocin (CR) employing a Drosophila model of Parkinsonism. Rotenone (ROT) has been extensively used as a model neurotoxin to induce Parkinson’s disease (PD) like symptoms in mice. In the present study, as a proof of concept we evaluated the efficacy of CR prophylaxis (25 mg/ kg bw/d, 7d) to attenuate ROT(0.5 mg/Kg bw/d,7d) -induced neurotoxic effects in male mice focussing on neurobehavioural assessments and biochemical determinants in the striatum. CR prophylaxis significantly alleviated ROT-induced behavioural alterations such as increased anxiety, diminished exploratory behaviour, decreased motor co-ordination, and grip strength. Concomitantly, we evidenced diminution of oxidative stress markers, enhanced levels of antioxidant enzyme and mitochondrial enzyme function in the striatal region. Further, varying degree of restoration of cholinergic function, dopamine and α-synuclein levels were discernible suggesting the possible mechanism/s of action of CR in this model. Based on our earlier data in flies and in worm model, we propose its use as an adjuvant therapeutic agent in oxidative stress-mediated neurodegenerative conditions such as PD.

Keywords

Crocin Neuroprotection Rotenone Parkinson’s disease Neurotoxicity 

Notes

Acknowledgments

The authors sincerely thank the Director, CSIR-CFTRI for his encouragement. The first author thanks the Indian Council of Medical Research (ICMR), New Delhi, for the award of Senior Research Fellowship.

Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126 https://www.sciencedirect.com/science/article/pii/S0076687984050163 CrossRefGoogle Scholar
  2. Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh S-A, Yousefi A et al (2010) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology 207:637–643 https://www.ncbi.nlm.nih.gov/pubmed/19838862 CrossRefGoogle Scholar
  3. Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317–324 https://www.ncbi.nlm.nih.gov/pubmed/12385818 CrossRefGoogle Scholar
  4. Alavizadeh SH, Hosseinzadeh H (2014) Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol 64:65–80 https://www.ncbi.nlm.nih.gov/pubmed/24275090 CrossRefGoogle Scholar
  5. Amin B, Malekzadeh M, Heidari MR, Hosseinzadeh H (2015) Effect of Crocus sativus extracts and its active constituent safranal on the harmaline-induced tremor in mice. Iran J Basic Med Sci 18:449–458 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475652/ Google Scholar
  6. Aruoma OI, Bahorun T, Jen L-S (2003) Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat Res Mutat Res 544:203–215 https://www.ncbi.nlm.nih.gov/pubmed/14644322 CrossRefGoogle Scholar
  7. Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial Electron transport in MTT reduction. Arch Biochem Biophys 303:474–482 https://www.ncbi.nlm.nih.gov/pubmed/8390225 CrossRefGoogle Scholar
  8. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306.  https://doi.org/10.1038/81834 CrossRefGoogle Scholar
  9. Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson’s disease. BioEssays 24:308–318 https://www.ncbi.nlm.nih.gov/pubmed/11948617 CrossRefGoogle Scholar
  10. Borland MK, Trimmer PA, Rubinstein JD, Keeney PM, Mohanakumar K, Liu L, Bennett JP (2008) Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson’s disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol Neurodegener 3:21 https://www.ncbi.nlm.nih.gov/pubmed/14766796 CrossRefGoogle Scholar
  11. Caito SW, Aschner M (2015) Mitochondrial redox dysfunction and environmental exposures. Antioxid Redox Signal 23:578–595 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544749/ CrossRefGoogle Scholar
  12. Cannon JR, Greenamyre JT (2014) Rotenone as preclinical model compound in Parkinson disease. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 995–1012 https://link.springer.com/content/pdf/10.1007%2F978-1-4614-5836-4.pdf Google Scholar
  13. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, Jia L, Yin H-X, Chen C (2008) Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: a relationship investigation between antioxidant activity and crocin contents. Food Chem 109:484–492 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375186/ CrossRefGoogle Scholar
  14. Chen L, Qi Y, Yang X (2015) Neuroprotective effects of Crocin against oxidative stress induced by ischemia/reperfusion injury in rat retina. Ophthalmic Res 54:157–168 https://www.ncbi.nlm.nih.gov/pubmed/26437379 CrossRefGoogle Scholar
  15. Choi B-M, Pae H-O, Jang SI, Kim Y-M, Chung H-T (2002) Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 35:116–126 https://www.ncbi.nlm.nih.gov/pubmed/16248976 Google Scholar
  16. Christodoulou E, Kadoglou NP, Kostomitsopoulos N, Valsami G (2015) Saffron: a natural product with potential pharmaceutical applications. J Pharm Pharmacol 67:1634–1649 https://www.ncbi.nlm.nih.gov/pubmed/26272123 CrossRefGoogle Scholar
  17. Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson’s disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30:475–483 https://www.ncbi.nlm.nih.gov/pubmed/19729209 CrossRefGoogle Scholar
  18. Classics Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 https://www.ncbi.nlm.nih.gov/pubmed/14907713 Google Scholar
  19. Dalpiaz A, Filosa R, de Caprariis P, Conte G, Bortolotti F, Biondi C, Scatturin A, Prasad PD, Pavan B (2007) Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 336:133–139 https://www.ncbi.nlm.nih.gov/pubmed/17184941 CrossRefGoogle Scholar
  20. Driver AS, Kodavanti PRS, Mundy WR (2000) Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22:175–181 https://www.ncbi.nlm.nih.gov/pubmed/10758346 CrossRefGoogle Scholar
  21. Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 51:1014–1026 https://www.ncbi.nlm.nih.gov/pubmed/21130159 CrossRefGoogle Scholar
  22. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77 https://www.sciencedirect.com/science/article/pii/0003986159900906 CrossRefGoogle Scholar
  23. Ellman GL, Courtney KD, Andres j V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95 https://www.sciencedirect.com/science/article/pii/0006295261901459 CrossRefGoogle Scholar
  24. Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 753:157–162 https://www.ncbi.nlm.nih.gov/pubmed/9125443 CrossRefGoogle Scholar
  25. Georgiadou G, Grivas V, Tarantilis PA, Pitsikas N (2014) Crocins, the active constituents of crocus Sativus L., counteracted ketamine–induced behavioural deficits in rats. Psychopharmacology 231:717–726 https://www.ncbi.nlm.nih.gov/pubmed/24096536 CrossRefGoogle Scholar
  26. Geromichalos GD, Lamari FN, Papandreou MA, Trafalis DT, Margarity M, Papageorgiou A, Sinakos Z (2012) Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies. J Agric Food Chem 60:6131–6138 https://www.ncbi.nlm.nih.gov/pubmed/23201480 CrossRefGoogle Scholar
  27. Gokul K, Muralidhara (2014) Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson’s disease. Neurochem Res 39:1382–1394 https://app.dimensions.ai/details/publication/pub.1040597458?and_facet_researcher=ur.01352574232.78 CrossRefGoogle Scholar
  28. Goldman SM (2014) Environmental toxins and Parkinson’s disease. Annu Rev Pharmacol Toxicol 54:141–164 https://www.ncbi.nlm.nih.gov/pubmed/24050700 CrossRefGoogle Scholar
  29. Guthenberg C, Ålin P, Mannervik B (1985) Glutathione transferase from rat testis. In: Meister A (ed) Methods in enzymology, vol. volume 113. Academic Press, pp 507–510 https://www.sciencedirect.com/science/journal/00766879/113/supp/C
  30. Höglinger GU, Carrard G, Michel PP, Medja F, Lombès A, Ruberg M, Friguet B, Hirsch EC (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease. J Neurochem 86:1297–1307 https://www.ncbi.nlm.nih.gov/pubmed/12911637 CrossRefGoogle Scholar
  31. Hattori N (2004) Etiology and pathogenesis of Parkinson’s disease: from mitochondrial dysfunctions to familial Parkinson’s disease. Rinshō Shinkeigaku Clin Neurol 44:241–262. http://scholar.google.co.in/scholar_url?url=https://europepmc.org/abstract/med/15287506&hl=en&sa=X&scisig=AAGBfm3k4849c1x9msw3YV-vrJCc-hoAAw&nossl=1&oi=scholarr
  32. Höglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, Féger J, Champy P, Prigent A, Medja F, Lombes A, Oertel WH, Ruberg M et al (2005) The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 95:930–939 https://www.ncbi.nlm.nih.gov/pubmed/16219024 CrossRefGoogle Scholar
  33. Hosseinzadeh H, Jahanian Z (2010) Effect of crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res 24:726–730 https://www.ncbi.nlm.nih.gov/pubmed/19827024 Google Scholar
  34. Hosseinzadeh H, Nassiri-Asl M (2013) Avicenna’s (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytother Res 27:475–483 https://www.ncbi.nlm.nih.gov/pubmed/22815242 CrossRefGoogle Scholar
  35. Hosseinzadeh H, Noraei NB (2009) Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 23:768–774 https://www.ncbi.nlm.nih.gov/pubmed/19142981 CrossRefGoogle Scholar
  36. Hosseinzadeh H, Sadeghnia HR (2007) Effect of safranal, a constituent of Crocus sativus (saffron), on methyl methanesulfonate (MMS)-induced DNA damage in mouse organs: an alkaline single-cell gel electrophoresis (comet) assay. DNA Cell Biol 26:841–846.  https://doi.org/10.1089/dna.2007.0631 CrossRefGoogle Scholar
  37. Hosseinzadeh H, Shamsaie F, Mehri S (2009) Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacogn Mag 5:419 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986099/ Google Scholar
  38. Jnaneshwari S, Hemshekhar M, Santhosh MS, Sunitha K, Thushara R, Thirunavukkarasu C, Kemparaju K, Girish KS (2013) Crocin, a dietary colorant mitigates cyclophosphamide-induced organ toxicity by modulating antioxidant status and inflammatory cytokines. J Pharm Pharmacol 65:604–614 https://www.ncbi.nlm.nih.gov/pubmed/23488790 CrossRefGoogle Scholar
  39. Karimi E, Oskoueian E, Hendra R, Jaafar HZE (2010) Evaluation of Crocus sativus L. Stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules 15:6244–6256 https://www.ncbi.nlm.nih.gov/pubmed/20877220 CrossRefGoogle Scholar
  40. Karlsson M, Ehinger JK, Piel S, Sjövall F, Henriksnäs J, Höglund U, Hansson MJ, Elmér E (2016) Changes in energy metabolism due to acute rotenone-induced mitochondrial complex I dysfunction – an in vivo large animal model. Mitochondrion 31:56–62 https://www.ncbi.nlm.nih.gov/pubmed/27769952 CrossRefGoogle Scholar
  41. Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, M Tsatsakis A (2015) The effects of Crocus sativus (saffron) and its constituents on nervous system: a review. Avicenna J Phytomed 5:376–391 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599112/ Google Scholar
  42. Kim J-H, Park G-Y, Bang SY, Park SY, Bae S-K, Kim Y (2014) Crocin suppresses LPS-stimulated expression of inducible nitric oxide synthase by upregulation of Heme Oxygenase-1 via calcium/calmodulin-dependent protein kinase 4. Mediat Inflamm:e728709 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627889/
  43. Kostyuk VA, Potapovich AI (1989) Superoxide--driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem Int 19:1117–1124 https://www.ncbi.nlm.nih.gov/pubmed/2561443 Google Scholar
  44. Lapointe N, St-Hilaire M, Martinoli M-G, Blanchet J, Gould P, Rouillard C, Cicchetti F (2004) Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J 18:717–719 https://www.ncbi.nlm.nih.gov/pubmed/14766796 CrossRefGoogle Scholar
  45. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478 https://www.ncbi.nlm.nih.gov/pubmed/1978225 CrossRefGoogle Scholar
  46. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278:8516–8525 https://www.ncbi.nlm.nih.gov/pubmed/12496265 CrossRefGoogle Scholar
  47. Luthman M, Holmgren A (1982) Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry (Mosc) 21:6628–6633 https://europepmc.org/abstract/med/7159551 CrossRefGoogle Scholar
  48. Manjunath MJ, Muralidhara (2015) Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. J Food Sci Technol 52:1971–1981 https://www.ncbi.nlm.nih.gov/pubmed/25829577 CrossRefGoogle Scholar
  49. Mashmoul M, Azlan A, Khaza’ai H, Mohd Yusof BN, Mohd Noor S (2013) Saffron: a natural potent antioxidant as a promising anti-obesity drug. Antioxidants 2:293–308 https://www.ncbi.nlm.nih.gov/pubmed/26784466 CrossRefGoogle Scholar
  50. Mokrasch LC, Teschke EJ (1984) Glutathione content of cultured cells and rodent brain regions: a specific fluorometric assay. Anal Biochem 140:506–509 https://www.sciencedirect.com/science/article/pii/000326978490201X CrossRefGoogle Scholar
  51. Molina-Jiménez MF, Sánchez-Reus MI, Cascales M, Andrés D, Benedí J (2005) Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine. Toxicol Appl Pharmacol 209:214–225 https://www.ncbi.nlm.nih.gov/pubmed/15904944 CrossRefGoogle Scholar
  52. Moreadith RW, Fiskum G (1984) Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal Biochem 137:360–367 https://www.ncbi.nlm.nih.gov/pubmed/6731817 CrossRefGoogle Scholar
  53. Murakami A (2013) Modulation of protein quality control systems by food phytochemicals. J Clin Biochem Nutr 52:215–227 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652296/ CrossRefGoogle Scholar
  54. Navarro A, Gomez C, López-Cepero JM, Boveris A (2004) Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol - Regul Integr Comp Physiol 286:R505–R511.  https://doi.org/10.1152/ajpregu.00208.2003 CrossRefGoogle Scholar
  55. Nisticò R, Mehdawy B, Piccirilli S, Mercuri N (2011) Paraquat-and rotenone-induced models of Parkinson’s disease. Int J Immunopathol Pharmacol 24:313–322.  https://doi.org/10.1177/039463201102400205 CrossRefGoogle Scholar
  56. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358 https://www.ncbi.nlm.nih.gov/pubmed/36810 CrossRefGoogle Scholar
  57. Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, Margarity M (2011) Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res 219:197–204 https://www.ncbi.nlm.nih.gov/pubmed/21238492 CrossRefGoogle Scholar
  58. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529 https://www.ncbi.nlm.nih.gov/pubmed/2871560 CrossRefGoogle Scholar
  59. Pennington RJ (1961) Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 80:649–654 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1243280/ CrossRefGoogle Scholar
  60. Poewe W (2008) Non-motor symptoms in Parkinson’s disease. Eur J Neurol 15:14–20 https://www.ncbi.nlm.nih.gov/pubmed/18353132 CrossRefGoogle Scholar
  61. Prasad SN, Muralidhara (2012) Neuroprotective efficacy of eugenol and Isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence. Neurochem Res 38:330–345 https://www.ncbi.nlm.nih.gov/pubmed/23161090 CrossRefGoogle Scholar
  62. Prediger RDS, Matheus FC, Schwarzbold ML, Lima MMS, Vital MABF (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115–124 https://www.ncbi.nlm.nih.gov/pubmed/21903105 CrossRefGoogle Scholar
  63. Rao SV, Mohandas G, Muralidhara RPS (2016a) Neuromodulatory potential of aqueous extracts of cumin, cinnamon: evidence from rotenone model in Drosophila: implications to Parkinson’s disease. Int J Neurol Res 2:297–307 http://www.ghrnet.org/index.php/ijnr/article/view/1904/2229 CrossRefGoogle Scholar
  64. Rao SV, Muralidhara YSC, Rajini PS (2016b) Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism. NeuroToxicology 52:230–242 https://www.ncbi.nlm.nih.gov/pubmed/26705857 CrossRefGoogle Scholar
  65. Rao SV, Salim C, Muralidhara, Rajini PS (2018) Crocin, a carotenoid mitigates acrylamide induced phenotypic alterations, oxidative stress and dopaminergic neurodegeneration in Caenorhabditis elegans: implications for neuropathy. Pharmaceut Drug Regula Affair J 1(1):000102 https://medwinpublishers.com/PDRAJ/PDRAJ16000102.pdf Google Scholar
  66. Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut P-O, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA et al (2014) Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75:351–362 https://www.ncbi.nlm.nih.gov/pubmed/24243558 CrossRefGoogle Scholar
  67. Rozas G, Guerra MJ, Labandeira-Garcı́a JL (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Protocol 2:75–84 https://www.ncbi.nlm.nih.gov/pubmed/9438075 CrossRefGoogle Scholar
  68. Sanberg PR, Bunsey MD, Giordano M, Norman AB (1988) The catalepsy test: its ups and downs. Behav Neurosci 102:748–759 https://www.ncbi.nlm.nih.gov/pubmed/2904271 CrossRefGoogle Scholar
  69. Santiago RM, Barbieiro J, Lima MMS, Dombrowski PA, Andreatini R, Vital MABF (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson’s disease are predominantly associated with serotonin and dopamine. Prog Neuro-Psychopharmacol Biol Psychiatry 34:1104–1114 https://www.ncbi.nlm.nih.gov/pubmed/20547199 CrossRefGoogle Scholar
  70. Sherer TB, Betarbet R, Greenamyre JT (2002) Environment, mitochondria, and Parkinson’s disease. Neuroscientist 8:192–197 https://www.ncbi.nlm.nih.gov/pubmed/12061498 Google Scholar
  71. Sherer TB, Kim J-H, Betarbet R, Greenamyre JT (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-Synuclein aggregation. Exp Neurol 179:9–16 https://www.ncbi.nlm.nih.gov/pubmed/12504863 CrossRefGoogle Scholar
  72. Shinomol GK, Mythri RB, Srinivas Bharath MM, Muralidhara (2012) Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain. Cell Mol Neurobiol 32:455–465 https://www.ncbi.nlm.nih.gov/pubmed/22160863 CrossRefGoogle Scholar
  73. Srivastava R, Ahmed H, Dixit RK, Dharamveer SSA (2010) Crocus sativus L.: a comprehensive review. Pharmacogn Rev 4:200–208 https://www.ncbi.nlm.nih.gov/pubmed/22228962 CrossRefGoogle Scholar
  74. Swarnkar S, Singh S, Mathur R, Patro IK, Nath C (2010) A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats. Toxicology 272:17–22 https://www.ncbi.nlm.nih.gov/pubmed/20371261 CrossRefGoogle Scholar
  75. Taylor TN, Greene JG, Miller GW (2010) Behavioral phenotyping of mouse models of Parkinson’s disease. Behav Brain Res 211:1–10 https://www.ncbi.nlm.nih.gov/pubmed/20211655 CrossRefGoogle Scholar
  76. Testa CM, Sherer TB, Greenamyre JT (2005) Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Mol Brain Res 134:109–118 https://www.ncbi.nlm.nih.gov/pubmed/15790535 CrossRefGoogle Scholar
  77. Vrbacký M, Drahota Z, Mrácek T, Vojtísková A, Jesina P, Stopka P, Houstek J (2007) Respiratory chain components involved in the glycerophosphate dehydrogenase-dependent ROS production by brown adipose tissue mitochondria. Biochim Biophys Acta 1767:989–997 https://www.ncbi.nlm.nih.gov/pubmed/17560536 CrossRefGoogle Scholar
  78. Wąsik A, Antkiewicz-Michaluk L (2017) The mechanism of neuroprotective action of natural compounds. Pharmacol Rep 69:851–860 https://www.ncbi.nlm.nih.gov/pubmed/28623709 CrossRefGoogle Scholar
  79. Wen Y, Li W, Poteet EC et al (2011) Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem 286(18):16504–16515 https://www.ncbi.nlm.nih.gov/pubmed/21454572 CrossRefGoogle Scholar
  80. Wolff SP (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. In: Enzymology B-M in (ed.), vol. 233. Academic Press:182–189. https://www.ncbi.nlm.nih.gov/pubmed/1519766
  81. Zhang X, Lu L, Liu S, Ye W, Wu J, Zhang X (2013) Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson’s disease. Int J Biochem Cell Biol 45:265–272 https://www.ncbi.nlm.nih.gov/pubmed/23201480 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of BiochemistryMysuruIndia
  2. 2.Food Protectants and Infestation Control DepartmentCSIR-Central Food Technological Research Institute (CFTRI)MysuruIndia

Personalised recommendations